News Quantified

NVAX – novavax, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Is Novavax (NVAX) Now Pricing In Too Much Risk After Its Recent Volatility [Yahoo! Finance]

Therapeutics Q4 Earnings: Novavax (NASDAQ:NVAX) Simply the Best [Yahoo! Finance]

Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA) [Yahoo! Finance]

Novavax (NVAX) Outperforms Broader Market: What You Need to Know [Yahoo! Finance]

Novavax (NVAX) had its "buy" rating reaffirmed by B. Riley Financial, Inc..

21.8%

BEAT

-0.8%

MISS

13.6%

BEAT

-4.4%

BEAT

Form SCHEDULE 13G/A NOVAVAX INC Filed by: BANK OF AMERICA CORP /DE/

Form ARS NOVAVAX INC For: Dec 31

Form DEFA14A NOVAVAX INC

Form DEF 14A NOVAVAX INC For: Jun 18

Form 4 NOVAVAX INC For: Apr 14 Filed by: Walker Robert Edward

Top News Gainers

8/14 Novavax, Inc. (NASDAQ: NVAX) had its price target raised by analysts at HC Wainwright from $10.00 to $17.00. They now have a "buy" rating on the stock. 40.5%

5/13 Form 4 NOVAVAX INC For: May 13 Filed by: Glenn Gregory M 30.6%

3/17 Novavax, Inc. (NASDAQ: NVAX) was upgraded by analysts at Cantor Fitzgerald from a "neutral" rating to an "overweight" rating. They now have a $16.00 price target on the stock, up previously from $6.00. 23.9%

11/27 Novavax, Inc. (NASDAQ: NVAX) is now covered by analysts at B. Riley. They set a "buy" rating and a $12.00 price target on the stock. 21.3%

1/21 Experimental-vaccine stocks jump amid spread of new virus in China [MarketWatch] 19.6%

3/24 Novavax’ NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial 18.8%

4/8 Novavax Identifies Coronavirus Vaccine Candidate; Accelerates Initiation of First-in-Human Trial to Mid-May 15.3%

2/26 Novavax Advances Development of Novel COVID-19 Vaccine 14.5%

12/31 Form S-3 NOVAVAX INC 13.7%

6/27 Novavax and Catalent Biologics Enter Strategic Partnership: Allowing Catalent Biologics to Expand Gene Therapy Footprint with Acquisition of Novavax’ Manufacturing Assets and Capabilities 12.6%

Top News Decliners

3/2 Form 8-K NOVAVAX INC For: Mar 02 -28.2%

1/21 Form 424B5 NOVAVAX INC -22.9%

3/10 Epidemic response group ups coronavirus vaccine funding to $23.7 mln [Reuters] -20.5%

3/24 Novavax's stock rockets after late-stage trial for flu treatment achieves primary endpoints [MarketWatch] -18.5%

3/11 Form S-3ASR NOVAVAX INC -17.9%

3/14 Earnings Update: Novavax, Inc. Just Reported And Analysts Are Boosting Their Estimates [Yahoo! Finance News] -16.3%

1/28 Novavax, Inc. (NASDAQ: NVAX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -12.5%

3/25 Novavax, Inc. (NASDAQ: NVAX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -12.3%

5/8 Novavax Announces Reverse Stock Split of Common Stock -12.3%

4/21 Is This the Best Coronavirus Stock to Buy Now? [The Motley Fool] -11.2%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day